193 related articles for article (PubMed ID: 10749870)
21. Effects of bone CS-proteoglycans, DS-decorin, and DS-biglycan on hydroxyapatite formation in a gelatin gel.
Boskey AL; Spevak L; Doty SB; Rosenberg L
Calcif Tissue Int; 1997 Oct; 61(4):298-305. PubMed ID: 9312200
[TBL] [Abstract][Full Text] [Related]
22. Immobilization of dermatan sulphate on a silica matrix and its possible use as an affinity chromatography support for heparin cofactor II purification.
Sinniger V; Tapon-Bretaudière J; Zhou FL; Bros A; Muller D; Jozefonvicz J; Fischer AM
J Chromatogr; 1991 Feb; 539(2):289-96. PubMed ID: 1646210
[TBL] [Abstract][Full Text] [Related]
23. Anticoagulant dermatan sulfate proteoglycan (decorin) in the term human placenta.
Delorme MA; Xu L; Berry L; Mitchell L; Andrew M
Thromb Res; 1998 May; 90(4):147-53. PubMed ID: 9692613
[TBL] [Abstract][Full Text] [Related]
24. Contribution of basic residues of the A helix of heparin cofactor II to heparin- or dermatan sulfate-mediated thrombin inhibition.
Hayakawa Y; Hirashima Y; Kurimoto M; Hayashi N; Hamada H; Kuwayama N; Endo S
FEBS Lett; 2002 Jul; 522(1-3):147-50. PubMed ID: 12095635
[TBL] [Abstract][Full Text] [Related]
25. The N-terminal acidic domain of heparin cofactor II mediates the inhibition of alpha-thrombin in the presence of glycosaminoglycans.
Van Deerlin VM; Tollefsen DM
J Biol Chem; 1991 Oct; 266(30):20223-31. PubMed ID: 1939083
[TBL] [Abstract][Full Text] [Related]
26. Structural and conformational aspects of the anticoagulant and anti-thrombotic activity of heparin and dermatan sulfate.
Casu B; Guerrini M; Torri G
Curr Pharm Des; 2004; 10(9):939-49. PubMed ID: 15078125
[TBL] [Abstract][Full Text] [Related]
27. Thrombin inhibition by HCII in the presence of elastase-cleaved HCII and thrombin-HCII complex.
Maekawa H; Sato H; Tollefsen DM
Thromb Res; 2000 Dec; 100(5):443-51. PubMed ID: 11150588
[TBL] [Abstract][Full Text] [Related]
28. Decorin and biglycan of normal and pathologic human corneas.
Funderburgh JL; Hevelone ND; Roth MR; Funderburgh ML; Rodrigues MR; Nirankari VS; Conrad GW
Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1957-64. PubMed ID: 9727420
[TBL] [Abstract][Full Text] [Related]
29. Isolation and characterization of matrix proteoglycans from human nasal cartilage. Compositional and structural comparison between normal and scoliotic tissues.
Theocharis AD; Karamanos NK; Papageorgakopoulou N; Tsiganos CP; Theocharis DA
Biochim Biophys Acta; 2002 Jan; 1569(1-3):117-26. PubMed ID: 11853965
[TBL] [Abstract][Full Text] [Related]
30. Aspartic acid residues 72 and 75 and tyrosine-sulfate 73 of heparin cofactor II promote intramolecular interactions during glycosaminoglycan binding and thrombin inhibition.
Mitchell JW; Church FC
J Biol Chem; 2002 May; 277(22):19823-30. PubMed ID: 11856753
[TBL] [Abstract][Full Text] [Related]
31. Characterization of chondroitin/dermatan sulfate proteoglycans synthesized by bovine retinal pericytes in culture.
Kaji T; Sakurai S; Yamamoto C; Fujiwara Y; Yamagishi S; Yamamoto H; Kinsella MG; Wight TN
Biol Pharm Bull; 2004 Nov; 27(11):1763-8. PubMed ID: 15516719
[TBL] [Abstract][Full Text] [Related]
32. The preferred pathway of glycosaminoglycan-accelerated inactivation of thrombin by heparin cofactor II.
Verhamme IM; Bock PE; Jackson CM
J Biol Chem; 2004 Mar; 279(11):9785-95. PubMed ID: 14701814
[TBL] [Abstract][Full Text] [Related]
33. Proteoglycans of Wharton's jelly.
Gogiel T; Bańkowski E; Jaworski S
Int J Biochem Cell Biol; 2003 Oct; 35(10):1461-9. PubMed ID: 12818241
[TBL] [Abstract][Full Text] [Related]
34. Modulation of heparin cofactor II activity by glycosaminoglycans and adhesive glycoproteins.
Petzelbauer E; Seiffert D; Beckmann R; Pusch B; Geiger M; Binder BR
Thromb Res; 1992 Jun; 66(5):559-67. PubMed ID: 1381850
[TBL] [Abstract][Full Text] [Related]
35. Differential expression of small chondroitin/dermatan sulfate proteoglycans, PG-I/biglycan and PG-II/decorin, by vascular smooth muscle and endothelial cells in culture.
Järveläinen HT; Kinsella MG; Wight TN; Sandell LJ
J Biol Chem; 1991 Dec; 266(34):23274-81. PubMed ID: 1744124
[TBL] [Abstract][Full Text] [Related]
36. Heparin cofactor IIOslo. Mutation of Arg-189 to His decreases the affinity for dermatan sulfate.
Blinder MA; Andersson TR; Abildgaard U; Tollefsen DM
J Biol Chem; 1989 Mar; 264(9):5128-33. PubMed ID: 2647747
[TBL] [Abstract][Full Text] [Related]
37. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta.
Hildebrand A; Romarís M; Rasmussen LM; Heinegård D; Twardzik DR; Border WA; Ruoslahti E
Biochem J; 1994 Sep; 302 ( Pt 2)(Pt 2):527-34. PubMed ID: 8093006
[TBL] [Abstract][Full Text] [Related]
38. Defective glycosylation of decorin and biglycan, altered collagen structure, and abnormal phenotype of the skin fibroblasts of an Ehlers-Danlos syndrome patient carrying the novel Arg270Cys substitution in galactosyltransferase I (beta4GalT-7).
Seidler DG; Faiyaz-Ul-Haque M; Hansen U; Yip GW; Zaidi SH; Teebi AS; Kiesel L; Götte M
J Mol Med (Berl); 2006 Jul; 84(7):583-94. PubMed ID: 16583246
[TBL] [Abstract][Full Text] [Related]
39. Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries.
Riessen R; Isner JM; Blessing E; Loushin C; Nikol S; Wight TN
Am J Pathol; 1994 May; 144(5):962-74. PubMed ID: 8178945
[TBL] [Abstract][Full Text] [Related]
40. Molecular size of dermatan sulfate oligosaccharides required to bind and activate heparin cofactor II.
Tollefsen DM; Peacock ME; Monafo WJ
J Biol Chem; 1986 Jul; 261(19):8854-8. PubMed ID: 3755134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
